CyMedica Orthopedics Receives FDA Clearance for e-vive Therapy

CyMedica Orthopedics received FDA 510(k) clearance for e-vive™, an app-controlled, data-driven muscle activation therapy and patient engagement solution for anterior cruciate ligament and total knee replacement patients.

The app works with embedded garment sensor technology to transmit data points (e.g. range of motion, activity levels, pain...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us